Improve production capacity and export potential of Comac Medical Ltd., through the purchase of high-tech assets.

Comac Medical Ltd. is challenged to cope with the ever increasing number of clinical trials in which the company operates and the associated increased volume of research on the one hand and expanded their range of another, and at the same time it is necessary to meet international standards for clinical laboratory diagnostics. Comac Medical Ltd.strives to meet the increasing demands and to consolidate its position as the local and global market, to increase the production capacity of the lab , reducing the processing time for their implementation through the introduction of two new software systems in order to pool all available laboratory facilities in a single system. The function of the first software that is intended to be implemented is the recruitment tests for all lab equipment from one place and the second software will process the results of tests by aggregate and put them in a specific database and will be archived in the format required for their retention. The aim is to reduce the processing time and the amount of moisture manual labor in the appointment of the tests and the processing and aggregation of results. At this stage Comac Medical Ltd. has a clinical laboratory equipped with various devices, each has an adjoining software, which separately bring patient data and appointed tests. With the new software system aims to patient data are entered into a single system from which to send the data and appoint tests simultaneously to all devices. After carrying out tests at the time the result was taken out and prints of each instrument separately, then provide the result to third parties for further processing or analysis.. The purpose of the second software system is to store information for long retention and for further restructuring in order this information to be available for external parties as the sponsors of the studies or external data management providers.

Comments
Leave a comment

Overview

Status Closed (completion date)
Start date 29 Mar, 2016
End date 21 Dec, 2016
Contract date 29 Mar, 2016
View in UMIS

Financial information

Total cost 1,672,760.00
Grant 951,973.50
Self finance 720,786.50
Total paid 945,965.61
EU participation percent 85.0%

Location